Publications by authors named "David Krag"

Claim this Profile
C
Context-based evidence: Pilot study to extract, repurpose, and distribute published data on OUD.
Alexander Sheppard, Carly Milliren, Douglas Schatz, David Krag

J Opioid Manag· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer therapy via neoepitope-specific monoclonal antibody cocktails.
Colin J Hartman, Asmaa O Mohamed, Girja S Shukla, Stephanie C Pero, Yu-Jing Sun, David N Krag

Cancer Immunol Immunother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Speed and accuracy of online searches by legislators and medical students using RefBin's opioid use disorder database.
Katelynn Giroux, David Krag, Richard Single, Shania Prytherch, Sydney White

Am J Drug Alcohol Abuse· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the COVID-19 pandemic on melanoma diagnosis and presentation: a `review.
James E Fanning, Simran Kalsi, David N Krag

Int J Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid dependence among pregnant and post-partum incarcerated individuals: A review of the literature.
Serra Sozen, David Krag, Carly Milliren

J Opioid Manag· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of palpable B16-F10 melanoma tumors with polyclonal antibodies on white blood cells.
Girja S Shukla, Stephanie C Pero, Linda Mei, Yu-Jing Sun, David N Krag

J Immunol Methods· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot trial comparing COVID-19 publication database to conventional online search methods.
Camille Torfs-Leibman, Takamaru Ashikaga, David Krag, Shania Lunna, Sarah Robtoy

BMJ Health Care Inform· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Clinical-Grade Antibodies against Tumor-Specific Mutations to Target Neuroblastoma.
Stephanie C Pero, Abhinav B Nagulapally, Linda Mei, Fan Zhang, Giselle S Sholler, David N Krag

Ann Clin Lab Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Refbin' an online platform to extract and classify large-scale information: a pilot study of COVID-19 related papers.
Shania Lunna, Isabelle Flinn, James Prytherch, Camille Torfs-Leibman, Sarah Robtoy, David Krag

BMJ Health Care Inform· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation of clinical-grade WBCs using leukocyte reduction filters.
Girja S Shukla, Stephanie C Pero, Linda Mei, Shelly Hitchcox, Mark Fung, David N Krag

J Immunol Methods· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cocktail of polyclonal affinity enriched antibodies against melanoma mutations increases binding and inhibits tumor growth.
Girja S Shukla, Yu-Jing Sun, Stephanie C Pero, David N Krag

J Immunol Methods· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses.
Girja S Shukla, Yu-Jing Sun, Stephanie C Pero, Giselle S Sholler, David N Krag

J Immunol Methods· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer metastasis through the lympho-vascular system.
S David Nathanson, David Krag, Henry M Kuerer, Lisa A Newman, Markus Brown

Clin Exp Metastasis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel lymph node B cells can predict disease-free survival in breast cancer patients.
Kim R M Blenman, Ting-Fang He, Paul H Frankel, Nora H Ruel, Erich J Schwartz, David N Krag

NPJ Breast Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential expression of Oct3/4 in human breast cancer and normal tissues.
Feng-Qi Zhao, Yogi Misra, Da-Biao Li, Marilyn P Wadsworth, David Krag

Int J Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node.
Jonathan R McDaniel, Stephanie C Pero, William N Voss, Girja S Shukla, Yujing Sun, Christopher C Krag, David N Krag

Cancer Immunol Immunother· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of sentinel node-derived antibodies from breast cancer patients.
Girja S Shukla, Stephanie C Pero, Yu-Jing Sun, Chelsea L Carman, Seth Harlow, David N Krag

J Immunol Methods· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies.
Girja S Shukla, Walter C Olson, Stephanie C Pero, Yu-Jing Sun, Chelsea L Carman, David N Krag

J Transl Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine draining lymph nodes are a source of antigen-specific B cells.
Stephanie C Pero, Yu-Jing Sun, Girja S Shukla, Chelsea L Carman, Christopher C Krag, David N Krag

Vaccine· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internal mammary sentinel lymph node biopsy in clinical practice.
Mehdi Asadi, David Krag

Int J Surg· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous antibodies that bind neuroblastoma cells.
Yujing Sun, Giselle S Sholler, Girja S Shukla, Stephanie C Pero, Chelsea L Carman, David N Krag

J Immunol Methods· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of tumor-binding scFv derived from clonally related B cells in tumor and lymph node of a patient with breast cancer.
Leah J Novinger, Takamaru Ashikaga, David N Krag

Cancer Immunol Immunother· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining axillary concordance rate for different injection locations in sentinel node mapping of breast cancer: how ambitious can we get?
Ramin Sadeghi, Mehdi Asadi, Giorgio Treglia, Seyed Rasoul Zakavi, Asiehsadat Fattahi, David N Krag

Breast Cancer Res Treat· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary concordance between superficial and deep sentinel node mapping material injections in breast cancer patients: systematic review and meta-analysis of the literature.
Ramin Sadeghi, Mehdi Asadi, Giorgio Treglia, Seyed Rasoul Zakavi, Asiehsadat Fattahi, David N Krag

Breast Cancer Res Treat· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patients.
Andrew Y Chang, Nupur Bhattacharya, Jian Mu, A Francesca Setiadi, Valeria Carcamo-Cavazos, David N Krag

J Transl Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis